The identification of BRCA2 as a member (FANCD1) of the Fanconi anaemia group of genes has raised the possibility that variation in other Fanconi anaemia genes may predispose to breast or ovarian cancer. This evidence concerns the gene BRCA2 and ovarian cancer.